Author Question: Culver et al. (2004) tested for differences in coping responses in middle-class African Americans, ... (Read 101 times)

james0929

  • Hero Member
  • *****
  • Posts: 586
Culver et al. (2004) tested for differences in coping responses in middle-class African Americans, Latinos, and European American women with early-stage breast cancer. They found only two differences in coping. Compared with European American women, the other two groups used this type of coping more:
 
  a. meditation c. mental imaging
  b. humor-based d. religion-based

Question 2

African Americans with chronic illness have:
 
  a. the same outcomes as European Americans in the United States.
  b. poorer outcomes than European Americans in the United States.
  c. better outcomes than European Americans in the United States.
  d. better outcomes than any other ethnic group in the United States.



gasdhashg

  • Sr. Member
  • ****
  • Posts: 335
Answer to Question 1

D

Answer to Question 2

B



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Automated pill dispensing systems have alarms to alert patients when the correct dosing time has arrived. Most systems work with many varieties of medications, so patients who are taking a variety of drugs can still be in control of their dose regimen.

Did you know?

ACTH levels are normally highest in the early morning (between 6 and 8 A.M.) and lowest in the evening (between 6 and 11 P.M.). Therefore, a doctor who suspects abnormal levels looks for low ACTH in the morning and high ACTH in the evening.

Did you know?

As many as 20% of Americans have been infected by the fungus known as Histoplasmosis. While most people are asymptomatic or only have slight symptoms, infection can progress to a rapid and potentially fatal superinfection.

Did you know?

Elderly adults are living longer, and causes of death are shifting. At the same time, autopsy rates are at or near their lowest in history.

Did you know?

Calcitonin is a naturally occurring hormone. In women who are at least 5 years beyond menopause, it slows bone loss and increases spinal bone density.

For a complete list of videos, visit our video library